Europe Cancer Treatment Drugs Market Report 2016

October 2016 | 122 pages | ID: E2DA56C949FEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cancer Treatment Drugs

Revenue, means the sales value of Cancer Treatment Drugs

This report studies sales (consumption) of Cancer Treatment Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Dendreon
• GlaxoSmithKline
• Merck
• Sanofi
• Vaccinogen
• Vaxon Biotech
• Vical
• Aduro BioTech
• Advantagene
• Advaxis
• Agenus
• AlphaVax
• Altor BioScience
• Amgen
• Antigen Express
• Argos Therapeutics
• Biothera
• Bristol-Myers Squibb
• Celldex Therapeutics
• Cel-Sci
• CureVac
• Cytos
• Galena Biopharma
• Gradalis
• Heat Biologics

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Cancer Treatment Drugs in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Cancer Treatment Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Cancer Treatment Drugs Market Report 2016

1 CANCER TREATMENT DRUGS OVERVIEW

1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Classification of Cancer Treatment Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Cancer Treatment Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Cancer Treatment Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Cancer Treatment Drugs (2011-2021)
  1.5.1 Europe Cancer Treatment Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Europe Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE CANCER TREATMENT DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Cancer Treatment Drugs Market Competition by Manufacturers
  2.1.1 Europe Cancer Treatment Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Cancer Treatment Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Cancer Treatment Drugs (Volume and Value) by Type
  2.2.1 Europe Cancer Treatment Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Cancer Treatment Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Cancer Treatment Drugs (Volume and Value) by Countries
  2.3.1 Europe Cancer Treatment Drugs Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Cancer Treatment Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Cancer Treatment Drugs (Volume) by Application

3 GERMANY CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Cancer Treatment Drugs Sales and Value (2011-2016)
  3.1.1 Germany Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
  3.1.2 Germany Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Cancer Treatment Drugs Sales Price Trend (2011-2016)
3.2 Germany Cancer Treatment Drugs Sales and Market Share by Manufacturers
3.3 Germany Cancer Treatment Drugs Sales and Market Share by Type
3.4 Germany Cancer Treatment Drugs Sales and Market Share by Application

4 FRANCE CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Cancer Treatment Drugs Sales and Value (2011-2016)
  4.1.1 France Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
  4.1.2 France Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
  4.1.4 France Cancer Treatment Drugs Sales Price Trend (2011-2016)
4.2 France Cancer Treatment Drugs Sales and Market Share by Manufacturers
4.3 France Cancer Treatment Drugs Sales and Market Share by Type
4.4 France Cancer Treatment Drugs Sales and Market Share by Application

5 UK CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Cancer Treatment Drugs Sales and Value (2011-2016)
  5.1.1 UK Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
  5.1.2 UK Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
  5.1.5 UK Cancer Treatment Drugs Sales Price Trend (2011-2016)
5.2 UK Cancer Treatment Drugs Sales and Market Share by Manufacturers
5.3 UK Cancer Treatment Drugs Sales and Market Share by Type
5.4 UK Cancer Treatment Drugs Sales and Market Share by Application

6 RUSSIA CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Cancer Treatment Drugs Sales and Value (2011-2016)
  6.1.1 Russia Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Russia Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Cancer Treatment Drugs Sales Price Trend (2011-2016)
6.2 Russia Cancer Treatment Drugs Sales and Market Share by Manufacturers
6.3 Russia Cancer Treatment Drugs Sales and Market Share by Type
6.4 Russia Cancer Treatment Drugs Sales and Market Share by Application

7 ITALY CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Cancer Treatment Drugs Sales and Value (2011-2016)
  7.1.1 Italy Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Italy Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Cancer Treatment Drugs Sales Price Trend (2011-2016)
7.2 Italy Cancer Treatment Drugs Sales and Market Share by Manufacturers
7.3 Italy Cancer Treatment Drugs Sales and Market Share by Type
7.4 Italy Cancer Treatment Drugs Sales and Market Share by Application

8 SPAIN CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Cancer Treatment Drugs Sales and Value (2011-2016)
  8.1.1 Spain Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Spain Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Cancer Treatment Drugs Sales Price Trend (2011-2016)
8.2 Spain Cancer Treatment Drugs Sales and Market Share by Manufacturers
8.3 Spain Cancer Treatment Drugs Sales and Market Share by Type
8.4 Spain Cancer Treatment Drugs Sales and Market Share by Application

9 BENELUX CANCER TREATMENT DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Cancer Treatment Drugs Sales and Value (2011-2016)
  9.1.1 Benelux Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Cancer Treatment Drugs Sales Price Trend (2011-2016)
9.2 Benelux Cancer Treatment Drugs Sales and Market Share by Manufacturers
9.3 Benelux Cancer Treatment Drugs Sales and Market Share by Type
9.4 Benelux Cancer Treatment Drugs Sales and Market Share by Application

10 EUROPE CANCER TREATMENT DRUGS MANUFACTURERS ANALYSIS

10.1 Dendreon
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Cancer Treatment Drugs Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Dendreon Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 GlaxoSmithKline
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Cancer Treatment Drugs Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 GlaxoSmithKline Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Merck
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Cancer Treatment Drugs Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Merck Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Sanofi
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Cancer Treatment Drugs Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Sanofi Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Vaccinogen
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Cancer Treatment Drugs Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Vaccinogen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Vaxon Biotech
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Cancer Treatment Drugs Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Vaxon Biotech Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Vical
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Cancer Treatment Drugs Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Vical Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Aduro BioTech
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Cancer Treatment Drugs Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Aduro BioTech Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Advantagene
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Cancer Treatment Drugs Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Advantagene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Advaxis
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Cancer Treatment Drugs Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Advaxis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Agenus
10.12 AlphaVax
10.13 Altor BioScience
10.14 Amgen
10.15 Antigen Express
10.16 Argos Therapeutics
10.17 Biothera
10.18 Bristol-Myers Squibb
10.19 Celldex Therapeutics
10.20 Cel-Sci
10.21 CureVac
10.22 Cytos
10.23 Galena Biopharma
10.24 Gradalis
10.25 Heat Biologics

11 CANCER TREATMENT DRUGS MANUFACTURING COST ANALYSIS

11.1 Cancer Treatment Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Treatment Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Cancer Treatment Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE CANCER TREATMENT DRUGS MARKET FORECAST (2016-2021)

14.1 Germany Cancer Treatment Drugs Sales Forecast (2016-2021)
14.2 France Cancer Treatment Drugs Sales Forecast (2016-2021)
14.3 UK Cancer Treatment Drugs Sales Forecast (2016-2021)
14.4 Russia Cancer Treatment Drugs Sales Forecast (2016-2021)
14.5 Italy Cancer Treatment Drugs Sales Forecast (2016-2021)
14.6 Spain Cancer Treatment Drugs Sales Forecast (2016-2021)
14.7 Benelux Cancer Treatment Drugs Sales Forecast (2016-2021)
14.8 Europe Cancer Treatment Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Cancer Treatment Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Treatment Drugs
Table Classification of Cancer Treatment Drugs
Figure Europe Sales Market Share of Cancer Treatment Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Cancer Treatment Drugs
Figure Europe Sales Market Share of Cancer Treatment Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)
Figure France Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)
Figure UK Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Cancer Treatment Drugs Sales and Growth Rate (2011-2021)
Figure Europe Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)
Table Europe Cancer Treatment Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Cancer Treatment Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Treatment Drugs Sales Share by Manufacturers
Figure 2016 Cancer Treatment Drugs Sales Share by Manufacturers
Table Europe Cancer Treatment Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Cancer Treatment Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cancer Treatment Drugs Revenue Share by Manufacturers
Table 2016 Europe Cancer Treatment Drugs Revenue Share by Manufacturers
Table Europe Cancer Treatment Drugs Sales and Market Share by Type (2011-2016)
Table Europe Cancer Treatment Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Cancer Treatment Drugs by Type (2011-2016)
Figure Europe Cancer Treatment Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Cancer Treatment Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Cancer Treatment Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Treatment Drugs by Type (2011-2016)
Figure Europe Cancer Treatment Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Cancer Treatment Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Cancer Treatment Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Cancer Treatment Drugs by Countries (2011-2016)
Table Europe Cancer Treatment Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Cancer Treatment Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Cancer Treatment Drugs by Countries (2011-2016)
Table Europe Cancer Treatment Drugs Sales and Market Share by Application (2011-2016)
Table Europe Cancer Treatment Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Cancer Treatment Drugs by Application (2011-2016)
Figure Germany Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
Figure Germany Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Cancer Treatment Drugs Sales Price Trend (2011-2016)
Table Germany Cancer Treatment Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Cancer Treatment Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Cancer Treatment Drugs Sales by Type (2015 and 2016)
Table Germany Cancer Treatment Drugs Market Share by Type (2015 and 2016)
Table Germany Cancer Treatment Drugs Sales by Application (2015 and 2016)
Table Germany Cancer Treatment Drugs Market Share by Application (2015 and 2016)
Figure France Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
Figure France Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
Figure France Cancer Treatment Drugs Sales Price Trend (2011-2016)
Table France Cancer Treatment Drugs Sales by Manufacturers (2015 and 2016)
Table France Cancer Treatment Drugs Market Share by Manufacturers (2015 and 2016)
Table France Cancer Treatment Drugs Sales by Type (2015 and 2016)
Table France Cancer Treatment Drugs Market Share by Type (2015 and 2016)
Table France Cancer Treatment Drugs Sales by Application (2015 and 2016)
Table France Cancer Treatment Drugs Market Share by Application (2015 and 2016)
Figure UK Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
Figure UK Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
Figure UK Cancer Treatment Drugs Sales Price Trend (2011-2016)
Table UK Cancer Treatment Drugs Sales by Manufacturers (2015 and 2016)
Table UK Cancer Treatment Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Cancer Treatment Drugs Sales by Type (2015 and 2016)
Table UK Cancer Treatment Drugs Market Share by Type (2015 and 2016)
Table UK Cancer Treatment Drugs Sales by Application (2015 and 2016)
Table UK Cancer Treatment Drugs Market Share by Application (2015 and 2016)
Figure Russia Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
Figure Russia Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Cancer Treatment Drugs Sales Price Trend (2011-2016)
Table Russia Cancer Treatment Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Cancer Treatment Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Cancer Treatment Drugs Sales by Type (2015 and 2016)
Table Russia Cancer Treatment Drugs Market Share by Type (2015 and 2016)
Table Russia Cancer Treatment Drugs Sales by Application (2015 and 2016)
Table Russia Cancer Treatment Drugs Market Share by Application (2015 and 2016)
Figure Italy Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
Figure Italy Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Cancer Treatment Drugs Sales Price Trend (2011-2016)
Table Italy Cancer Treatment Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Cancer Treatment Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Cancer Treatment Drugs Sales by Type (2015 and 2016)
Table Italy Cancer Treatment Drugs Market Share by Type (2015 and 2016)
Table Italy Cancer Treatment Drugs Sales by Application (2015 and 2016)
Table Italy Cancer Treatment Drugs Market Share by Application (2015 and 2016)
Figure Spain Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
Figure Spain Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Cancer Treatment Drugs Sales Price Trend (2011-2016)
Table Spain Cancer Treatment Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Cancer Treatment Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Cancer Treatment Drugs Sales by Type (2015 and 2016)
Table Spain Cancer Treatment Drugs Market Share by Type (2015 and 2016)
Table Spain Cancer Treatment Drugs Sales by Application (2015 and 2016)
Table Spain Cancer Treatment Drugs Market Share by Application (2015 and 2016)
Figure Benelux Cancer Treatment Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Cancer Treatment Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Cancer Treatment Drugs Sales Price Trend (2011-2016)
Table Benelux Cancer Treatment Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Cancer Treatment Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Cancer Treatment Drugs Sales by Type (2015 and 2016)
Table Benelux Cancer Treatment Drugs Market Share by Type (2015 and 2016)
Table Benelux Cancer Treatment Drugs Sales by Application (2015 and 2016)
Table Benelux Cancer Treatment Drugs Market Share by Application (2015 and 2016)
Table Cancer Treatment Drugs Basic Information List
Table Dendreon Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Cancer Treatment Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Vaccinogen Basic Information List
Table Vaccinogen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaccinogen Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Vaxon Biotech Basic Information List
Table Vaxon Biotech Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaxon Biotech Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Vical Basic Information List
Table Vical Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Aduro BioTech Basic Information List
Table Aduro BioTech Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aduro BioTech Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Advantagene Basic Information List
Table Advantagene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advantagene Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Advaxis Basic Information List
Table Advaxis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advaxis Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Agenus Basic Information List
Table Agenus Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agenus Cancer Treatment Drugs Sales Market Share (2011-2016)
Table AlphaVax Basic Information List
Table AlphaVax Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AlphaVax Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Altor BioScience Basic Information List
Table Altor BioScience Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Altor BioScience Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Antigen Express Basic Information List
Table Antigen Express Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Antigen Express Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Argos Therapeutics Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Biothera Basic Information List
Table Biothera Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biothera Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celldex Therapeutics Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Cel-Sci Basic Information List
Table Cel-Sci Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cel-Sci Cancer Treatment Drugs Sales Market Share (2011-2016)
Table CureVac Basic Information List
Table CureVac Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table CureVac Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Cytos Basic Information List
Table Cytos Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cytos Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Galena Biopharma Basic Information List
Table Galena Biopharma Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galena Biopharma Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Gradalis Basic Information List
Table Gradalis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gradalis Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Heat Biologics Basic Information List
Table Heat Biologics Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heat Biologics Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Treatment Drugs
Figure Manufacturing Process Analysis of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2015
Table Major Buyers of Cancer Treatment Drugs
Table Distributors/Traders List
Figure Germany Cancer Treatment Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Cancer Treatment Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Cancer Treatment Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Cancer Treatment Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Cancer Treatment Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Cancer Treatment Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Treatment Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Treatment Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Treatment Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Treatment Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Treatment Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Treatment Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Treatment Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Treatment Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Cancer Treatment Drugs Sales Forecast by Type (2016-2021)
Table Europe Cancer Treatment Drugs Sales Forecast by Application (2016-2021)